Price $54.50 |
Market Cap
3.05B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.26
|
P/S
3.16
|
Dividend %
-
|
|
P/CF
416.7
|
P/FCF
30.5
|
Op. Cash Flow
155.3K
|
FCF
1.8
|
|
Op. Margin
-2.20%
|
Net Margin
-3.10%
|
ROE
-3.10%
|
ROI
1.30%
|
|
ROA
-1.70%
|
EPS Growth
-254.60%
|
Current Ratio
2.5
|
Debt/Equity
45.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $3.92 | - | - | 147.3M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.33 | - | - | 62.4M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $9.41 | - | - | 10.73B | Strong Buy |
| IRIDEX Corporation (IRIX) | $1.85 | - | - | 23.6M | Strong Buy |
| DENTSPLY SIRONA Inc (XRAY) | $50.61 | - | 0.80% | 11.22B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
